Inventor · disambiguated record
Ying Zhao
Also filed as: ZHAO YING · ZHAO YING-MING
18 granted patents·12 pending applications·45 citations·filing 1996–2024
90Inventor score
Files withST JUDE CHILDRENS RES HOSPITAL5DIAPIN THERAPEUTICS LLC2UNIV ZHEJIANG2AGENCY SCIENCE TECH & RES1BEIJING HUAAN INNOVATION BIOTECHNOLOGY CO LTD1
Top patents by PatentIndex Score
30 records- 0180US11884743B2Preparation and application of an intact recombinant antibody specific to clothianidin based on the identified variable region sequenceUNIV ZHEJIANG·Filed 2020·Granted Jan 30, 2024·2 cites·7 claims
- 0280US10822377B2Substituted urea depsipeptide analogs as activators of the ClpP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2019·Granted Nov 3, 2020·1 cites·18 claims
- 0376US10100090B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2016·Granted Oct 16, 2018·2 cites·20 claims
- 0476US9879050B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDREN'S RES HOSPITAL·Filed 2014·Granted Jan 30, 2018·2 cites·20 claims
- 0576US8361515B2Extracts of Chenopodium ambrosioides L., the compositions comprising said extracts, the preparing process and application thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2006·Granted Jan 29, 2013·3 cites·20 claims
- 0676US2025064082A1Solid plant protein compositions with improved physical and/or organolpetic properties and methods of making and using thereofEAT JUST INC·Filed 2024·Application pending·0 cites
- 0773US6228654B1Methods for structure analysis of oligosaccharidesSCRIPPS RESEARCH INST·Filed 1996·Granted May 8, 2001·31 cites·7 claims
- 0872US10676510B2Substituted urea depsipeptide analogs as activators of the ClpP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2018·Granted Jun 9, 2020·1 cites·9 claims
- 0966US9278945B2Relating to propylene oxide purificationSHELL OIL CO·Filed 2014·Granted Mar 8, 2016·1 cites·14 claims
- 1066US2025178907A1Metal-loaded nanocarbon spheres, and preparation method and use thereofTHE SECOND HOSPITAL OF DALIAN MEDICAL UNIV·Filed 2024·Application pending·0 cites
- 1164US2025042973A1Recombinant protein of gperUNIV WUHAN·Filed 2024·Application pending·0 cites
- 1263US2025185635A1Genetically modified non-human animals with humanized immunoglobulin and mhc lociBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1362US10378147B2Pretreating agent to improve the effect of ink-jet printing on polyester fabric and its applicationUNIV JIANGNAN·Filed 2017·Granted Aug 13, 2019·0 cites·7 claims
- 1462US2023181673A1Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disordersDIAPIN THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 1561US8586108B2Extracts of Chenopodium ambrosioides L., the compositions comprising said extracts, the preparing process and application thereofYE ZHENGLIANG·Filed 2012·Granted Nov 19, 2013·1 cites·23 claims
- 1661US2020270311A1Substituted urea depsipeptide analogs as activators of the clpp endopeptidaseST JUDE CHILDREN'S HOSPITAL·Filed 2020·Application pending·0 cites
- 1758US2011195136A1Drop pill for treating coronary heart disease and preparation thereofCHEN JIANMING·Filed 2009·Application pending·0 cites
- 1857US12180304B2Variable region sequence of broad-spectrum antibody against clothianidin and dinotefuran and preparation of intact recombinant antibody thereofUNIV ZHEJIANG·Filed 2021·Granted Dec 31, 2024·0 cites·9 claims
- 1956US9443628B2Cement curing formulation and method for high-level radioactive boron waste resins from nuclear reactorZHAO YING·Filed 2011·Granted Sep 13, 2016·1 cites·16 claims
- 2056US2023321179A1N-acyl amino acid products and usesUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 2155US10457707B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2018·Granted Oct 29, 2019·0 cites·20 claims
- 2255US2023321104A1Use of pyrido[1,2-a]pyrimidinone compound in treating peripheral t cell lymphomaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2347US2021315963A1Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disordersDIAPIN THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2443US2023092425A1Method for preparing high-quality fuel oil and/or chemical raw material from biomass pyrolysis liquidHENAN BUF BIOENERGY CO LTD·Filed 2020·Application pending·0 cites
- 2542US10570179B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2017·Granted Feb 25, 2020·0 cites·20 claims
- 2639US10041010B2Process and device for treating catalyst discharged from bubbling bed hydrogenation of residual oilLI JIANPING·Filed 2012·Granted Aug 7, 2018·0 cites·12 claims
- 2738US11952734B2Ecological revetment for regulating wandering riversUNIV DALIAN TECH·Filed 2020·Granted Apr 9, 2024·0 cites·7 claims
- 2838US2015197773A1Methods for bladder cancer therapy using baculoviral vectorsAGENCY SCIENCE TECH & RES·Filed 2013·Application pending·0 cites
- 2935US11772091B2Method and apparatus for treating, sorting and recycling oil-containing discharged catalystSHANGHAI HUACHANG ENV PROT CO LTD·Filed 2017·Granted Oct 3, 2023·0 cites·10 claims
- 3033US9896498B2Tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereofBEIJING HUAAN INNOVATION BIOTECHNOLOGY CO LTD·Filed 2015·Granted Feb 20, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Ying Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →